Enhanced and Differential Capture of Circulating Tumor Cells from Lung Cancer Patients by Microfluidic Assays Using Aptamer Cocktail

Small. 2016 Feb 24;12(8):1072-81. doi: 10.1002/smll.201503188. Epub 2016 Jan 13.

Abstract

Collecting circulating tumor cells (CTCs) shed from solid tumor through a minimally invasive approach provides an opportunity to solve a long-standing oncology problem, the real-time monitoring of tumor state and analysis of tumor heterogeneity. However, efficient capture and detection of CTCs with diverse phenotypes is still challenging. In this work, a microfluidic assay is developed using the rationally-designed aptamer cocktails with synergistic effect. Enhanced and differential capture of CTCs for nonsmall cell lung cancer (NSCLC) patients is achieved. It is also demonstrated that the overall consideration of CTC counts obtained by multiple aptamer combinations can provide more comprehensive information in treatment monitoring.

Keywords: aptamers; cancer diagnosis; circulating tumor cells; rare cell enrichment; tumor heterogeneity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aptamers, Nucleotide / metabolism*
  • Cell Line, Tumor
  • Fluorescence
  • Humans
  • Lung Neoplasms / pathology*
  • Microfluidics / methods*
  • Nanowires
  • Neoplastic Cells, Circulating / pathology*
  • Reproducibility of Results
  • Silicon / chemistry

Substances

  • Aptamers, Nucleotide
  • Silicon